The largest database of trusted experimental protocols

3 protocols using igd pe clone ia6 2

1

ZIKV-Reactive B Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thawed PBMCs were stained with Aqua Vital Dye (Invitrogen), IgD-PE (clone IA6-2; BD Biosciences), CD10 PE-CF594 (clone HI10a; BD Biosciences; CD3 PE-Cy5 (clone HIT3a; BD Biosciences), CD14 BV605 (clone M5E2; BD Biolegend), CD16 BV570 (clone 3G8; Biolegend), CD27 PE-Cy7 (clone O323; Thermo Fisher Scientific), CD38 APC-AF700 (clone LS198-4-3; Beckman Coulter), CD19 APC-Cy7 (clone SJ25C1; BD Biosciences) and 1 x 106 PFU of freshly thawed UV-inactivated ZIKV labelled with AF488. Additionally, 5 μM of Chk2 kinase inhibitor II (Calbiochem/EMD Chemicals) was added to prevent cell death. Unfractionated B cells were defined as CD14/CD16/CD3/CD19+. For memory B cells an additional IgD/CD27all gate was applied. The ZIKV-reactive AF488 gate was set using a fluorescence minus one condition. Cells were sorted on a Beckton Dickinson FACS Aria II and analysis was performed in FlowJo.
+ Open protocol
+ Expand
2

SARS-CoV-2-Specific B Cell Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze B cell populations and to identify SARS-CoV-2-specific B cells within PBMC by flow cytometry, a multi-color panel was developed. PBMCs were incubated with the BD human Fc block (BD Biosciences, Aalst, Belgium) for 10 min at RT. The cells were then stained with the SARS-CoV-2 spike full protein ECD-His recombinant biotinylated-protein (25 µg/mL, Sino Biological) in a staining buffer [PBS, 0.5% bovine serum albumin (BSA) and 2 mM EDTA, all from Sigma-Aldrich, St. Louis, MO, USA/Burlington, MA, USA] for 30 min at 4 °C, followed by staining with FITC- and Brillant-Violet-421-conjugated streptavidin for an additional 30 min at 4 °C. Subsequently, the cells were stained for 30 min at 4 °C using the subsequent antibody mixture, comprising CD3-PECy 7 (clone SK7), CD56-PECy7 (clone B159), CD14-PECy7 (clone M5E2), CD19-BUV395 (clone SJ25C1), IgM-BV605 (clone G20-127) and IgD-PE (clone IA6-2) (all from BD Biosciences, Belgium). The cells were then labeled with live/dead FSV780 following the manufacturer’s instructions (BD Biosciences). Finally, the cells were fixed using a BD fixation solution (BD Biosciences) and analyzed with an SO LSRFortessa X20 flow cytometer (BD Biosciences). Data analysis was conducted using FlowJo v10 (TreeStar, Ashland, OR, USA).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspensions from the BM and peripheral blood were first incubated with human BD Fc block (BD Biosciences) to block Fcγ receptor and then stained with the following anti-human Abs: CD19-APC (clone HIB19, BioLegend), CD34-PE (clone 563, BD Biosciences), CD20-FITC (clone 2H7, BioLegend), CD27-APC/Cyanine7 (clone O323, BioLegend), IgD-PE (clone IA6-2, BD Biosciences), IgM-FITC (clone G20-127, BD Biosciences), CD43-PE (clone CD43-10G7, BioLegend), CD38-PE/Cy7 (clone HIT2, BioLegend), CD38-Percp/Cy5.5 (clone HIT2, BD Biosciences), CD24-PE (clone ML5, BD Biosciences), CD27-V450 (clone M-T271, BD Biosciences), IgD-BV510 (clone IA6-2, BD Biosciences), IgG-PE/Cy7 (clone G18-145, BD Biosciences), Ki-67–PE (clone Ki-67, BioLegend), CD80-FITC (clone L307.4, BD Biosciences), CD86-PE (clone IT2.2, BD Biosciences), HLADR-PE (clone G46-6, BD Biosciences) and CD69-PE/Cy7 (clone FN50, BD Biosciences). 7-AAD Viability Staining Solution (eBioscience, Thermo Fisher Scientific) was used for live versus dead cell discrimination. Samples were analyzed with a FACSVerse flow cytometer (BD Biosciences) using the FACSuite software. Data analysis was performed with FlowJo 10 software (Treestar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!